Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis

Blood Cancer J. 2018 Jun 11;8(6):57. doi: 10.1038/s41408-018-0095-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Blast Crisis / pathology*
  • Cell Transformation, Neoplastic
  • Disease Progression
  • Female
  • Humans
  • Leukemia, Myeloid / diagnosis*
  • Leukemia, Myeloid / mortality
  • Male
  • Practice Guidelines as Topic / standards
  • Primary Myelofibrosis / diagnosis*
  • Primary Myelofibrosis / mortality
  • Prognosis
  • Reproducibility of Results
  • Survival Rate
  • World Health Organization